研發與技術
R&D and Technology
-
查看詳情 >
2023-Validation of Luminex immunological and competitive Luminex immunological assays in human serum for clinical assessment of a 14-valent recombinant human papillomavirus vaccine
A novel virus‐like particle (VLP)‐d multivalent recombinant human ...
2023-02-20 -
查看詳情 >
2023-Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines：a randomized phase 3 trial
As of April 2023 the SARS-CoV-2 infections remain a persistent gl...
2023-02-20 -
查看詳情 >
2023-Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
The safety and immunogenicity of a protein-d tetravalent vaccine ...
2023-02-20 -
查看詳情 >
2023-Mutation N856K in spike reduces fusogenicity and infectivity of Omicron BA.1-王慧玉
COVID-19 lung pathology is characterized by interstitial pneumoni...
2023-02-22 -
查看詳情 >
2023-Characterization of an Oil-in-Water Adjuvant and Its Interaction with Antigen Protein in Candidate COVID-19 Vaccine-呂華
Adjuvants are an essential component in the development of highly ...
2023-11-19 -
查看詳情 >
2023-Antitumor activity of pegylated human interferon β as monotherapy or in combination with immune checkpoint inhibitors via tumor growth inhibition and dendritic cell activation-汪瑞
Immune checkpoint inhibitors (ICIs) such as anti-programmed cell ...
2023-11-29 -
查看詳情 >
2023-A Randomized Double-Blind Parallel-Controlled Phase I Study Comparing the Pharmacokinetics Safety and Immunogenicity of SCT510 to Bevacizumab (Avastin®) in Healthy Chinese Males
The vascular endothelial growth factor (VEGF) particularly VEGF-A ...
2023-06-01 -
查看詳情 >
2023-A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine SCTV01A Showed High Immunogenicity and Low Toxicity in Animal Models
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led t...
2023-02-23